Delayed 68Ga-FAPI-46 PET/MR imaging confirms ongoing fibroblast activation in patients after acute myocardial infarction

Purpose of the Report: Combined cardiac 68Ga-Fibroblast-Activation Protein-alpha inhibitor (FAPI) positron-emission tomography (PET) and cardiac magnetic resonance imaging (MRI) constitute a novel diagnostic tool in patients for the assessment of myocardial damage after an acute myocardial infarctio...

Full description

Bibliographic Details
Published in:	International Journal of Cardiology: Heart & Vasculature
Main Authors:	Jana Kupusovic, Lukas Kessler, Sandra Kazek, Michal Kamil Chodyla, Lale Umutlu, Fadi Zarrad, Michael Nader, Wolfgang P. Fendler, Zohreh Varasteh, Ken Hermann, Dobromir Dobrev, Reza Wakili, Tienush Rassaf, Johannes Siebermair, Christoph Rischpler
Format:	Article
Language:	English
Published:	Elsevier 2024-02-01
Subjects:	FAPI Fibroblast activation Myocardial infarction Acute coronary syndrome Cardiovascular imaging PET/MRI
Online Access:	http://www.sciencedirect.com/science/article/pii/S235290672400006X

Similar Items

Fully-automated production of [68Ga]Ga-FAPI-46 for clinical application
by: Sarah Spreckelmeyer, et al.
Published: (2020-12-01)

Fully automated radiosynthesis of [68Ga]Ga-FAPI-46 with cyclotron produced gallium
by: Adam J. Rosenberg, et al.
Published: (2023-10-01)

PET/CT WITH 68GA-FAPI46 FOR THE DETECTION OF PRIMARY AND METASTATIC LESIONS IN PATIENTS WITH DIFFERENT TYPES OF CANCER. INITIAL EXPERIENCE
by: Lilian Yuri Itaya Yamaga, et al.
Published: (2025-05-01)

AUTOMATED SYNTHESIS AND IN VITRO STUDIES OF [68GA]GA-FAPI-46 IN HOSPITAL RADIOPHARMACY
by: Leonardo Lima Fuscaldi, et al.
Published: (2024-04-01)

Development of a versatile [68Ga]Ga-FAPI-46 automated synthesis suitable to multi-elutions of germanium-68/gallium-68 generators
by: Louis-Paul Paty, et al.
Published: (2024-07-01)

Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics
by: William Serumula, et al.
Published: (2025-04-01)

Preclinical evaluation of [68Ga]Ga-AAZTA-FAPI-46: a novel PET tracer for targeting fibroblast activation protein (FAP)
by: Rebecca Rizzo, et al.
Published: (2025-08-01)

Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the <sup>68</sup>Ga- and <sup>177</sup>Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA.(SA.FAPi)<sub>2</sub>
by: Tilman Läppchen, et al.
Published: (2024-06-01)

Fibroblast activation protein inhibitor (FAPI)-negative huge renal cell carcinoma demonstrating an intriguing pattern on [99mTc]Tc-FAPI-46 scintigraphy
by: Nasrin Raeisi, et al.
Published: (2025-08-01)

Automated synthesis of [68Ga]Ga-FAPI-46 without pre-purification of the generator eluate on three common synthesis modules and two generator types
by: Ammar Alfteimi, et al.
Published: (2022-07-01)

Diagnostic accuracy and clinical value of [68Ga]Ga-FAPI-46 PET/CT for staging patients with ovarian cancer: study protocol for a prospective clinical trial
by: Morten Bentestuen, et al.
Published: (2024-06-01)

Impact of FAPI-46/dual-tracer PET/CT imaging on radiotherapeutic management in esophageal cancer
by: Simone Wegen, et al.
Published: (2024-04-01)

Automated Synthesis of [<sup>68</sup>Ga]Ga-FAPI-46 on a Scintomics GRP Synthesizer
by: Elisabeth Plhak, et al.
Published: (2023-08-01)

FAPI-PET/CT guided radiotherapy for patients with esophageal cancer
by: Kai Kröger, et al.
Published: (2025-02-01)

[68Ga]Ga-FAPI-46 PET/CT for Staging Suspected/Confirmed Lung Cancer: Results on the Surgical Cohort Within a Monocentric Prospective Trial
by: Lucia Zanoni, et al.
Published: (2024-11-01)

Recent implications of FAPI PET in cardiac diseases
by: Lan Wang, et al.
Published: (2025-10-01)

New Fully Automated Preparation of High Apparent Molar Activity <sup>68</sup>Ga-FAPI-46 on a Trasis AiO Platform
by: Chiara Da Pieve, et al.
Published: (2022-01-01)

Imaging Inflammation with Positron Emission Tomography
by: Janette Iking, et al.
Published: (2021-02-01)

Synthesis and Preliminary Evaluation of FAPα Targeted Tracer 131I-FAPI-03
by: MA Huan1, 2, LIAO Jiali2, YANG Yuanyou2, LIU Ning2, LI Feize2
Published: (2024-04-01)

Automated Radiosynthesis and Micro PET/CT Imaging of 18F-FAPI-42
by: WANG Hua;WANG Meng;HUANG Shun;SUN Penghui;HU Kongzheng;XIANG Xianhong;LIN Weiyuan;ZHI Shengfang;TANG Ganghua;HAN Yanjiang
Published: (2023-08-01)

The synergy of 177Lu-FAPI-46 with tyrosine kinase inhibitor in a sarcoma patient-derived xenograft mouse model
by: Jing-Ren Tseng, et al.
Published: (2024-06-01)

Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience
by: Umut Elboga, et al.
Published: (2022-02-01)

Comparison of the value of FAPI imaging and speckle‑tracking echocardiography in assessment of right ventricular remodeling in pulmonary hypertension
by: Bi-Xi Chen, et al.
Published: (2025-03-01)

Molecular Imaging of Fibroblast Activation Protein in Response to Cardiac Injury Using [<sup>68</sup>Ga]Ga-DATA<sup>5m</sup>.SA.FAPi
by: Victoria Weissenböck, et al.
Published: (2025-04-01)

Comparative Imaging Analysis of Kimura&rsquo;s Disease Using 18F-FDG PET/CT and [18F]AlF-NOTA-FAPI-04 PET/CT
by: Sun C, et al.
Published: (2025-05-01)

The role of FAPI PET/CT in patients with lymphoma: a systematic review
by: Natale Quartuccio, et al.
Published: (2025-05-01)

FAPI PET/CT Imaging—An Updated Review
by: Kunal Ramesh Chandekar, et al.
Published: (2023-06-01)

Comparative diagnostic performance of [68Ga]Ga-FAPI-46 and [18F]FDG PET/CT imaging for the detection of active lesions and disease stage evaluation in breast cancer patients
by: Kiana Radmehr, et al.
Published: (2025-01-01)

Signet cell rectal carcinoma with prostatic involvement detected by FAPI-04 PET-MRI fusion
by: K. Arun Prashanth, et al.
Published: (2023-12-01)

Non-specific uptake of 18F-FAPI-04 in the pancreas and its related factors: a post-hoc analysis of an ongoing prospective clinical trial
by: Yan Li, et al.
Published: (2024-05-01)

Imaging Cancer-Associated Fibroblasts (CAFs) with FAPi PET
by: Laura Gilardi, et al.
Published: (2022-02-01)

Production and Quality Control of [<sup>68</sup>Ga]Ga-FAPI-46: Development of an Investigational Medicinal Product Dossier for a Bicentric Clinical Trial
by: Alessandro Cafaro, et al.
Published: (2025-09-01)

Head-to-head comparison of 18F-FDG and 68Ga-FAPI PET/CT in common gynecological malignancies
by: Tengfei Li, et al.
Published: (2025-02-01)

FAPI-positron emission tomography for radiotherapy in head and neck cancer: applications and future directions
by: Mischa de Ridder, et al.
Published: (2025-07-01)

Iliopsoas fibrosis after revision of total hip arthroplasty revealed by 68Ga-FAPI PET/CT: a case report
by: Yiqun Wang, et al.
Published: (2024-02-01)

Dynamic PET/CT Imaging of 68Ga-FAPI-04 in Chinese Subjects
by: Shuailiang Wang, et al.
Published: (2021-03-01)

First-In-Human Results on the Biodistribution, Pharmacokinetics, and Dosimetry of [<sup>177</sup>Lu]Lu-DOTA.SA.FAPi and [<sup>177</sup>Lu]Lu-DOTAGA.(SA.FAPi)<sub>2</sub>
by: Sanjana Ballal, et al.
Published: (2021-11-01)

Preliminary evaluation of FAPI-04-PET/CT for differentiating recurrence and post-treatment changes in high-grade gliomas
by: Indraja D. Dev, et al.
Published: (2024-10-01)

Non-specific uptake of 68Ga-FAPI PET/CT in the pancreas and its related factor: a retrospective, single-center study
by: Liu Xiao, et al.
Published: (2025-10-01)

[68Ga]Ga-FAPI PET/CT in brain tumors: comparison with [18F]F-FDG PET/CT
by: Ya Liu, et al.
Published: (2024-09-01)